B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 1.86 EUR 2.2% Market Closed
Market Cap: 37.8m EUR
Have any thoughts about
Bioretec Oy?
Write Note

Bioretec Oy
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bioretec Oy
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioretec Oy
OMXH:BRETEC
Current Portion of Long-Term Debt
€375k
CAGR 3-Years
70%
CAGR 5-Years
62%
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Current Portion of Long-Term Debt
€5.5m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
25%
M
Modulight Oyj
OMXH:MODU
Current Portion of Long-Term Debt
€2m
CAGR 3-Years
18%
CAGR 5-Years
96%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Current Portion of Long-Term Debt
€1.3m
CAGR 3-Years
46%
CAGR 5-Years
27%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Current Portion of Long-Term Debt
€1.5m
CAGR 3-Years
42%
CAGR 5-Years
0%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Current Portion of Long-Term Debt
€300k
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
-3%
No Stocks Found

Bioretec Oy
Glance View

Market Cap
37.8m EUR
Industry
Health Care

Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.

BRETEC Intrinsic Value
3.76 EUR
Undervaluation 51%
Intrinsic Value
Price
B

See Also

What is Bioretec Oy's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
375k EUR

Based on the financial report for Dec 31, 2023, Bioretec Oy's Current Portion of Long-Term Debt amounts to 375k EUR.

What is Bioretec Oy's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
62%

Over the last year, the Current Portion of Long-Term Debt growth was 3 591%. The average annual Current Portion of Long-Term Debt growth rates for Bioretec Oy have been 70% over the past three years , 62% over the past five years .

Back to Top